Masonic Cancer Center at University of Minnesota

Minneapolis, Minnesota 55455

7 studies enrolling now · 109 studies all time

What they study most

ALD (Adrenoleukodystrophy), AML, ART, Acquired Bone Marrow Failure Syndromes, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia/Lymphoma, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Acute Myelogenous Leukemia (AML), Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

Studies at this site

• Allo HSCT Using RIC and PTCy for Hematological Diseases — Recruiting now
• Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders — Recruiting now
• Adrenoleukodystrophy National Registry Study — Recruiting now
• GTB-5550 in Advanced Solid Tumors — Recruiting now
• MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases — Recruiting now
• Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders — Recruiting now
• Study of PAT in Patients With Solid Tumor Cancers — Recruiting now
• CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone — Completed
• Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids — Stopped early
• Sugars in Cigarettes — Completed
• MT2017-45: CAR-T Cell Therapy for Heme Malignancies — Running, not enrolling
• Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer — Running, not enrolling
• Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy — Running, not enrolling
• PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation — Completed
• UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep — Completed
• Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT — Completed
• Cytogenetic Studies in Acute Leukemia and Multiple Myeloma — Running, not enrolling
• Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes — Status unconfirmed
• A Study of FMT in Patients With AML Allo HSCT in Recipients — Completed
• Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia — Withdrawn before enrolling
• Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD — Completed
• Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy — Completed
• Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy — Completed
• Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT — Completed
• A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers — Completed
• Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors — Completed
• Allo HSCT Using RIC for Hematological Diseases — Completed
• Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia — Running, not enrolling
• Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia — Completed
• QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML — Completed
• Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer — Completed
• Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer — Completed
• Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer — Running, not enrolling
• PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma — Completed
• Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer — Completed
• Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720 — Completed
• Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors — Completed
• Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia — Status unconfirmed
• Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy — Completed
• CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig — Completed
• Trial of Indole-3-Carbinol and Silibinin — Completed
• Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma — Completed
• Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia — Completed
• Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant — Completed
• Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies — Stopped early
• Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases — Completed
• Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma — Completed
• Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer — Completed
• Pharmacokinetics of Daunorubicin in Young Patients With Cancer — Completed
• Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation — Completed